Polatuzumab outperforms pinatuzumab in non-Hodgkin lymphomaApril 5, 2019B Cell LymphomaFollicular Lymphoma
High survival in relapsed FL after primary radiotherapyMarch 21, 2019Follicular LymphomaB Cell Lymphoma
Anthracyclines, bendamustine are options for grade 3A follicular lymphomaFebruary 11, 2019Follicular LymphomaB Cell Lymphoma
Daratumumab disappoints in non-Hodgkin lymphoma trialFebruary 11, 2019Mantle Cell LymphomaFollicular LymphomaB Cell Lymphoma
BCL expression intensity key in distinguishing FL lesionsFebruary 10, 2019Follicular LymphomaB Cell Lymphoma
Phase 3 study confirms biosimilarity of PF-05280586 with rituximabDecember 5, 2018Follicular LymphomaB Cell Lymphoma
Cortactin expression aids in CLL-MCL differentialNovember 28, 2018CLLMantle Cell LymphomaFollicular Lymphoma